Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Repisalud
Publicación Artículo científico (JournalArticle)

Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database

  • Koeks, Zaïda
  • Bladen, Catherine L
  • Salgado, David
  • van Zwet, Erik
  • Pogoryelova, Oksana
  • McMacken, Grace
  • Monges, Soledad
  • Foncuberta, Maria E
  • Kekou, Kyriaki
  • Kosma, Konstantina
  • Dawkins, Hugh
  • Lamont, Leanne
  • Bellgard, Matthew I
  • Roy, Anna J
  • Chamova, Teodora
  • Guergueltcheva, Velina
  • Chan, Sophelia
  • Korngut, Lawrence
  • Campbell, Craig
  • Dai, Yi
  • Wang, Jen
  • Barišić, Nina
  • Brabec, Petr
  • Lähdetie, Jaana
  • Walter, Maggie C
  • Schreiber-Katz, Olivia
  • Karcagi, Veronika
  • Garami, Marta
  • Herczegfalvi, Agnes
  • Viswanathan, Venkatarman
  • Bayat, Farhad
  • Buccella, Filippo
  • Ferlini, Alessandra
  • Kimura, En
  • van den Bergen, Janneke C
  • Rodrigues, Miriam
  • Roxburgh, Richard
  • Lusakowska, Anna
  • Kostera-Pruszczyk, Anna
  • Santos, Rosário
  • Neagu, Elena
  • Artemieva, Svetlana
  • Rasic, Vedrana Milic
  • Vojinovic, Dina
  • Posada De la Paz, Manuel
  • Bloetzer, Clemens
  • Klein, Andrea
  • Díaz-Manera, Jordi
  • Gallardo, Eduard
  • Karaduman, A Ayşe
  • Oznur, Tunca
  • Topaloğlu, Haluk
  • El Sherif, Rasha
  • Stringer, Angela
  • Shatillo, Andriy V
  • Martin, Ann S
  • Peay, Holly L
  • Kirschner, Jan
  • Flanigan, Kevin M
  • Straub, Volker
  • Bushby, Kate
  • Béroud, Christophe
  • Verschuuren, Jan J
  • Lochmüller, Hanns
Background: Recent short-term clinical trials in patients with Duchenne Muscular Dystrophy (DMD) have indicated greater disease variability in terms of progression than expected. In addition, as average life-expectancy increases, reliable data is required on clinical progression in the older DMD population. Objective: To determine the effects of corticosteroids on major clinical outcomes of DMD in a large multinational cohort of genetically confirmed DMD patients. Methods: In this cross-sectional study we analysed clinical data from 5345 genetically confirmed DMD patients from 31 countries held within the TREAT-NMD global DMD database. For analysis patients were categorised by corticosteroid background and further stratified by age. Results: Loss of ambulation in non-steroid treated patients was 10 years and in corticosteroid treated patients 13 years old (p = 0.0001). Corticosteroid treated patients were less likely to need scoliosis surgery (p < 0.001) or ventilatory support (p < 0.001) and there was a mild cardioprotective effect of corticosteroids in the patient population aged 20 years and older (p = 0.0035). Patients with a single deletion of exon 45 showed an increased survival in contrast to other single exon deletions. Conclusions: This study provides data on clinical outcomes of DMD across many healthcare settings and including a sizeable cohort of older patients. Our data confirm the benefits of corticosteroid treatment on ambulation, need for scoliosis surgery, ventilation and, to a lesser extent, cardiomyopathy. This study underlines the importance of data collection via patient registries and the critical role of multi-centre collaboration in the rare disease field.
Repisalud
Publicación Artículo científico (JournalArticle)

The TREAT-NMD DMD Global Database: analysis of more than 7,000 Duchenne muscular dystrophy mutations

  • Bladen, Catherine L
  • Salgado, David
  • Monges, Soledad
  • Foncuberta, Maria E
  • Kekou, Kyriaki
  • Kosma, Konstantina
  • Dawkins, Hugh
  • Lamont, Leanne
  • Roy, Anna J
  • Chamova, Teodora
  • Guergueltcheva, Velina
  • Chan, Sophelia
  • Korngut, Lawrence
  • Campbell, Craig
  • Dai, Yi
  • Wang, Jen
  • Barišić, Nina
  • Brabec, Petr
  • Lähdetie, Jaana
  • Walter, Maggie C
  • Schreiber-Katz, Olivia
  • Karcagi, Veronika
  • Garami, Marta
  • Viswanathan, Venkatarman
  • Bayat, Farhad
  • Buccella, Filippo
  • Kimura, En
  • Koeks, Zaïda
  • van den Bergen, Janneke C
  • Rodrigues, Miriam
  • Roxburgh, Richard
  • Lusakowska, Anna
  • Kostera-Pruszczyk, Anna
  • Zimowski, Janusz
  • Santos, Rosário
  • Neagu, Elena
  • Artemieva, Svetlana
  • Rasic, Vedrana Milic
  • Vojinovic, Dina
  • Posada De la Paz, Manuel
  • Bloetzer, Clemens
  • Jeannet, Pierre-Yves
  • Joncourt, Franziska
  • Díaz-Manera, Jordi
  • Gallardo, Eduard
  • Karaduman, A Ayşe
  • Topaloğlu, Haluk
  • El Sherif, Rasha
  • Stringer, Angela
  • Shatillo, Andriy V
  • Martin, Ann S
  • Peay, Holly L
  • Bellgard, Matthew I
  • Kirschner, Jan
  • Flanigan, Kevin M
  • Straub, Volker
  • Bushby, Kate
  • Verschuuren, Jan
  • Aartsma-Rus, Annemieke
  • Béroud, Christophe
  • Lochmüller, Hanns
Analyzing the type and frequency of patient-specific mutations that give rise to Duchenne muscular dystrophy (DMD) is an invaluable tool for diagnostics, basic scientific research, trial planning, and improved clinical care. Locus-specific databases allow for the collection, organization, storage, and analysis of genetic variants of disease. Here, we describe the development and analysis of the TREAT-NMD DMD Global database (http://umd.be/TREAT_DMD/). We analyzed genetic data for 7,149 DMD mutations held within the database. A total of 5,682 large mutations were observed (80% of total mutations), of which 4,894 (86%) were deletions (1 exon or larger) and 784 (14%) were duplications (1 exon or larger). There were 1,445 small mutations (smaller than 1 exon, 20% of all mutations), of which 358 (25%) were small deletions and 132 (9%) small insertions and 199 (14%) affected the splice sites. Point mutations totalled 756 (52% of small mutations) with 726 (50%) nonsense mutations and 30 (2%) missense mutations. Finally, 22 (0.3%) mid-intronic mutations were observed. In addition, mutations were identified within the database that would potentially benefit from novel genetic therapies for DMD including stop codon read-through therapies (10% of total mutations) and exon skipping therapy (80% of deletions and 55% of total mutations).